GYRE THERAPEUTICS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for GYRE THERAPEUTICS, INC. (GYRE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are GYRE insiders buying or selling?
In the last 12 months, GYRE THERAPEUTICS, INC. insiders reported 0 open-market purchases ($0) and 9 sales ($952.9K) — net selling of $952.9K. Since March 2018, Trabud has recorded 76 Form 4 filings for GYRE: 20 buys ($123.1K) and 56 sells ($8.3M).
Source: SEC EDGAR Form 4
Key Statistics (March 2018 – Jun 22, 2026)
Total Form 4 filings
76
SEC EDGAR
Insider filers
13
Insider buys (20)
$123.1K
Insider sells (56)
$8.3M
Insider sentiment
Net sellingNet insider flow of $8.2M in net selling since March 2018, and $952.9K in net selling over the last 12 months.
Recent GYRE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 11.0K | $6.25 | $68.7K | SEC ↗ |
| Jun 15, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 2.8K | $6.17 | $17.3K | SEC ↗ |
| Jun 11, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 20.9K | $6.16 | $128.9K | SEC ↗ |
| Jun 8, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 35.0K | $6.25 | $218.6K | SEC ↗ |
| May 27, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 7.5K | $6.09 | $45.7K | SEC ↗ |
| May 22, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 22.2K | $6.15 | $136.7K | SEC ↗ |
| May 20, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 9.3K | $6.38 | $59.4K | SEC ↗ |
| May 18, 2026 | Weiguo Ye | Chief Operating Officer | Sale | 28.7K | $6.79 | $194.8K | SEC ↗ |
| May 8, 2026 | Luo Ying | Chief Executive Officer | Sale | 10.3K | $8.04 | $82.9K | SEC ↗ |
| May 29, 2025 | Ma Songjiang | President | Sale | 2.6K | $10.23 | $26.2K | SEC ↗ |
| May 27, 2025 | Ma Songjiang | President | Sale | 2.2K | $10.91 | $23.8K | SEC ↗ |
| May 22, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.04 | $44.2K | SEC ↗ |
| May 20, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.21 | $44.8K | SEC ↗ |
| May 16, 2025 | Ma Songjiang | President | Sale | 2.0K | $10.69 | $21.6K | SEC ↗ |
| May 14, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.97 | $43.9K | SEC ↗ |
| Mar 25, 2025 | Ma Songjiang | President | Sale | 174 | $10.00 | $1.7K | SEC ↗ |
| Mar 21, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.11 | $40.4K | SEC ↗ |
| Mar 19, 2025 | Ma Songjiang | President | Sale | 2.2K | $11.89 | $26.7K | SEC ↗ |
| Mar 17, 2025 | Ma Songjiang | President | Sale | 4.0K | $12.06 | $48.2K | SEC ↗ |
| Mar 13, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.57 | $46.3K | SEC ↗ |
| Mar 11, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.19 | $40.8K | SEC ↗ |
| Mar 7, 2025 | Ma Songjiang | President | Sale | 4.0K | $10.89 | $43.6K | SEC ↗ |
| Mar 5, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.05 | $44.2K | SEC ↗ |
| Mar 3, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.37 | $45.5K | SEC ↗ |
| Feb 27, 2025 | Ma Songjiang | President | Sale | 4.0K | $11.50 | $46.0K | SEC ↗ |
Showing the 25 most recent of 76 Form 4 filings for GYRE THERAPEUTICS, INC..
Most active GYRE insiders
- Ma Songjiang39 filings
- Nassim Usman10 filings
- Weiguo Ye8 filings
- Howard Levy5 filings
- Grant E. Blouse3 filings
Ask anything about GYRE insider activity
Use Trabud's AI agent to query GYRE THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me GYRE CEO purchases this year" or compare it against any other ticker.
Open the AI agentGYRE insider trading FAQ
Are GYRE THERAPEUTICS, INC. insiders buying or selling?
In the last 12 months, GYRE THERAPEUTICS, INC. insiders reported 0 open-market purchases ($0) and 9 sales ($952.9K) — net selling of $952.9K. Since March 2018, Trabud has recorded 76 Form 4 filings for GYRE: 20 buys ($123.1K) and 56 sells ($8.3M). Over the full record that is net selling of $8.2M.
How many insiders trade GYRE stock?
13 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for GYRE THERAPEUTICS, INC.. The most recent filing was accepted on Jun 22, 2026.
Where does Trabud get GYRE insider trading data?
All GYRE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.